Gene: ZNF713
Official Full Name: zinc finger protein 713provided by HGNC
Gene Summary: The protein encoded by this gene contains C2H2 zinc finger domains. In some individuals, a CGG-repeat expansion from 5-22 repeats to 68-450 repeats has been identified in the first intron of this gene. This mutation is thought to effect the expression of this gene and it has been proposed that it may be associated with Autistic Spectrum Disorder. [provided by RefSeq, Jul 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12031 | ZNF713 Knockout cell line (HeLa) | Human | ZNF713 | 1:3~1:6 | Negative | Online Inquiry |
KO12032 | ZNF713 Knockout cell line (HCT 116) | Human | ZNF713 | 1:2~1:4 | Negative | Online Inquiry |
KO12033 | ZNF713 Knockout cell line (HEK293) | Human | ZNF713 | 1:3~1:6 | Negative | Online Inquiry |
KO12034 | ZNF713 Knockout cell line (A549) | Human | ZNF713 | 1:3~1:4 | Negative | Online Inquiry |
ZNF713 Gene Knockout Cell Lines are specialized cell lines in which the ZNF713 gene has been functionally disrupted, rendering it inactive. This innovative product allows researchers to study the effects of the loss of this particular gene on cellular functions, pathways, and phenotypic outcomes. By employing CRISPR/Cas9 gene-editing technology, these knockout cell lines provide a streamlined approach to examining the role of ZNF713 in various biological processes, including cell differentiation, proliferation, and apoptosis.
The key function of ZNF713 knockout cell lines lies in their ability to serve as models for investigating gene function and disease mechanisms. This product enables researchers to conduct experiments aimed at elucidating the biological significance of ZNF713, which has been implicated in processes relevant to tumorigenesis and cellular stress responses. By comparing these knockout models with wild-type counterparts, scientists can uncover novel insights into the gene's role in health and disease.
The scientific importance of ZNF713 knockout cell lines extends to both basic and applied research, including drug discovery, cancer biology, and gene therapy. They offer an unparalleled resource for validating therapeutic targets and testing the efficacy of new drug candidates in pre-clinical studies.
What sets ZNF713 knockout cell lines apart from alternatives is their high specificity and reproducibility. Established in well-characterized backgrounds, these lines ensure precise gene disruption while maintaining cellular integrity. Additionally, they come with detailed validation data, allowing researchers to confidently interpret their results while saving time on preliminary validations.
For researchers and clinicians, the value of ZNF713 knockout cell lines lies in their potential to accelerate scientific discovery and therapeutic innovation. These cell lines facilitate the exploration of complex pathways and can uncover novel therapeutic strategies aimed at conditions where ZNF713 plays a pivotal role.
Our company is committed to advancing science by providing high-quality biological products. With a team of experienced scientists and a strong focus on innovation, we ensure that our offerings, including ZNF713 Gene Knockout Cell Lines, meet the highest standards for research excellence, empowering scientists and clinicians in their quest for knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.